COMMD9 has the potential to stimulate proliferation, migration, G1/S phase transition of the cell cycle, while inhibiting cellular autophagy in non-small cell lung cancer (NSCLC) 20, 21. The gene discussed is COMMD9; the disease is non-small cell lung carcinoma.